FDA Removes Black Box Warnings on Menopause HRT

Reviewed by Carly Morgan, MSN, FNP-C

Night sweats at 2 a.m., brain fog at 2 p.m., and a nagging worry every time someone mentions “hormones.” For many women, that is midlife on loop. Maybe you have tried cooling pillows, herbal teas, or sheer grit, while quietly wondering whether relief and long-term health for bones, heart, sleep, and mood must come at a cost. For years, the conversation around menopausal hormone therapy has been crowded with headlines, half-remembered studies, and cautionary fine print. But today, we have a clearer view of what’s true. If you have been told to tough it out, this is your invitation to revisit what modern evidence really says about menopause, symptoms, and the role hormone therapy can play.

Big changes for HRT

Despite all the stigma around hormone replacement therapy (HRT) for menopause, big changes are coming. On November 10, the FDA announced that it  will be removing the “black box” warning labels on menopausal hormone therapies.

These warnings have been creating fear in patients and practitioners alike for decades, based on questionable research from the early 2000s. The black box labels include warnings about increased risk for breast cancer, cardiovascular disease, and probable dementia in estrogen-containing HRT products. However, after reevaluating old and new research, the FDA determined that these labels are no longer needed, and probably never were. 

3 big myths to retire

It’s time to start changing the way we think about menopausal HRT. The removal of black box labels calls for some serious myth-busting about HRT.

Myth #1: “HRT increases your risk of breast cancer”

Reality: A meta-analysis of 30 trials with 26,708 participants found no increase in cancer mortality from HRT. HRT was even found to reduce total mortality in participants younger than 60.

Myth #2: “HRT will give you dementia”

Reality: HRT can actually reduce cognitive decline and Alzheimer’s in menopausal women. Research shows that HRT use is associated with a 64% reduction in cognitive decline, and 35% lower risk of Alzheimer’s.

Myth #3: “HRT can increase your risk of cardiovascular disease”

Reality: HRT does not increase your chance of developing cardiovascular disease. In fact, HRT is associated with a 50% reduction in heart attack risk, and estrogen can protect you against cardiovascular disease.

Where research first went wrong

If HRT is truly safe, then why did it have black box warnings in the first place? The answer lies in the original research.

The study that initially posed questions about breast cancer risk with HRT had several problems. The average age of women participating in the study was 63 years, yet the average age of a woman experiencing menopause is more than a decade younger than that. This means that age-related health conditions from older women in the study did not match the younger population of women who would be starting HRT. The study participants were also given a hormone formulation that is no longer being commonly used. Additionally, the study itself found a statistically non-significant increase in breast cancer diagnosis. A statistically non-significant result means that the incidence of more breast cancer diagnoses in that particular study is more likely coincidence than a real pattern. 

Other studies under the same initiative reported an increased risk of stroke and probable dementia from HRT. The study reporting an increased risk of stroke has an average age of 63 among participants, and the study reporting probably dementia evaluated only women aged 65-79 years. Just like with the breast cancer study, the much higher age of study participants did not align with the age of women who actually go on HRT (usually 45-55 years). Thus, the “increased risk” of stroke and dementia is more likely attributable to the greater age of participants than the HRT itself. 

In recent years, the FDA has considered the questionable validity of these studies, and asked whether the black box label is really necessary. As a result, the FDA held an Expert Panel on July 17 this year, followed by a period of public input. This culminated in the decision made on November 10, when the agency announced it would be removing the black box labels for breast cancer, cardiovascular disease, and probable dementia from menopausal HRT products. It is important to note that one black label remains for a risk of endometrial cancer in systemic estrogen-alone drugs. However, prescribing systemic estrogen-alone drugs is not common practice, especially in women with a uterus. 

The truth about HRT for menopause

Recent, reliable research ends the fearmongering around menopausal HRT. HRT has been proven to provide relief from common menopausal symptoms. This includes vasomotor symptoms, like hot flashes and night sweats, as well as vulvovaginal atrophy (changes to the vulva, vagina, or urinary tract caused by decreased estrogen). This can lead to vaginal dryness, pain during intercourse, and susceptibility to infections, among other symptoms. HRT can also support bone density and prevent osteoporosis in peri- or post-menopausal women. There is even an association between HRT and decreased mortality in women younger than 60.

What does this mean for women moving forward?

Now that the black box labels have been removed from most menopausal HRT products, women can feel much more confident about their decisions. Women no longer have to question whether they are trading menopausal relief for worse conditions down the road. Providers and patients alike will no longer live in fear about HRT, allowing them to make the best and most educated decision for each person. 

The removal of black box labels reflects much of the current sentiment around women’s healthcare. For too long, women have been left out of research, ignored in the doctor’s office, or told to tough it out.  This may seem like a small step for women’s health, but it is a major step in the right direction. There is still a lot of work to be done, but now patients and providers alike have better education and access to be able to make the right decisions. 

In the words of the Secretary of Health Robert F Kennedy,

“Today, we are standing up for every woman who has symptoms of menopause and is looking to know her options and receive potentially life-changing treatment…For more than two decades, bad science and bureaucratic inertia have resulted in women and physicians having an incomplete view of HRT. We are returning to evidence-based medicine and giving women control over their health again.”

RFK

Does this mean I should start HRT?

Now that the warnings around breast cancer, cardiovascular disease, and dementia have been removed from menopausal HRT products, many women are considering whether it’s time to start HRT. If you’re looking for relief from hot flashes, vaginal dryness, and more, HRT could be the right option for you. However, HRT isn’t for everyone. 

It’s important to remember that HRT still carries risks, especially for certain populations. Those with a history of breast cancer or clotting disorders should avoid HRT. Additionally, women with a uterus should not take systemic estrogen-only HRT. Instead, always pair estrogen with progesterone to alleviate this risk. 

How do I start HRT?

In the appropriate patient, menopausal HRT can be life-changing. So how do you start?

First, you’ll want to meet with a doctor and discuss your interest in HRT. They may or may not order a blood test to determine your baseline levels of estrogen, progesterone, and other hormones. From there, you will work with your provider to determine the right HRT medication based on your labs and symptoms. Once you start HRT, your provider may recommend routine bloodwork to check how well the medication is working.

For some, the hassle of in-office visits and long wait times at the lab may be a barrier to receiving proper care. Luckily, Geviti offers a solution. With Geviti Plus Rx, you get comprehensive bloodwork every 6 months (over 110 biomarkers), quarterly visits with a clinician, and access to custom HRT to fit your exact needs. Forget the hassle by ultilizing at-home blood draws, quarterly virtual appointments, and medication delivered to your doorstep. If you’re sick of traditional healthcare, consider a fresh, new solution like Geviti. 

Key Takeaways:

• Menopausal hormone replacement therapy (HRT) is a legitimate, evidence-based option for relieving symptoms like hot flashes, night sweats, brain fog, and vaginal dryness while also supporting bone, heart, and brain health for many women in midlife.
• The FDA’s decision to remove black box warnings for breast cancer, cardiovascular disease, and probable dementia from most menopausal HRT products reflects a re-evaluation of older, flawed studies and a shift back toward up-to-date, high-quality evidence.
• HRT is not right for everyone, but used in the right candidate and age range, it offers meaningful symptom relief and long-term benefits, and women now have more reason to feel confident revisiting this option with a knowledgeable clinician.

FAQs

1. Does the removal of black box warnings mean HRT is completely risk free?No. It means the old “high risk” message around breast cancer, cardiovascular disease, and dementia was overstated, not that HRT is risk free for everyone.

2. How do I know if I might be a good candidate for HRT?If you experiencing bothersome menopausal symptoms, you may be a candidate, and a clinician can confirm this by reviewing your health history and goals.

3. What if I have a history of breast cancer or clotting disorders?HRT is usually not recommended for those with a history of breast cancer or clotting disorders. See a trained healthcare provider who can evaluate your medical history and provide suitable options for menopausal symptom relief.

4. Do I need blood tests before or during HRT?Baseline and follow-up bloodwork are often helpful to personalize dosing and monitor safety, which is why programs like Geviti build regular labs into care.

5. How do I choose between different types and forms of HRT?Your provider will match the formulation and delivery method to your symptoms, health history, and preferences, and may use custom-compounded HRT when a more tailored approach is needed.